Impact of hemoglobin levels on tumor oxygenation: The higher, the better?

Strahlentherapie und Onkologie

Volumn 182, Issue 2, 2006, Pages 63-71

  Vaupel, Peter ^a   Mayer, Arnulf ^a   Höckel, Michael ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Anemia; Breast cancers; Hematocrit; Hemoglobin concentration; Squamous cell carcinomas; Tumor hypoxia; Tumor oxygenation

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; OXYGEN;

ANEMIA; BLOOD VISCOSITY; BREAST CANCER; CANCER SURVIVAL; CORRELATION ANALYSIS; ERYTHROCYTE TRANSFUSION; HEAD AND NECK CANCER; HEMOGLOBIN DETERMINATION; HISTOLOGY; HUMAN; HYPOXIA; NONHUMAN; OXYGEN TENSION; OXYGEN TRANSPORT; PHOTODYNAMIC THERAPY; PROGNOSIS; REVIEW; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; TISSUE OXYGENATION; TREATMENT FAILURE; TUMOR GROWTH; TUMOR VASCULARIZATION; UTERINE CERVIX CANCER; VULVA CANCER;

ADULT; ANEMIA; ANIMALS; BREAST NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; CELL SURVIVAL; FEMALE; HEMATOCRIT; HEMOGLOBINOMETRY; HUMANS; MALE; NEOPLASMS, EXPERIMENTAL; OTORHINOLARYNGOLOGIC NEOPLASMS; OXYGEN; OXYGEN CONSUMPTION; UTERINE CERVICAL NEOPLASMS; VULVAR NEOPLASMS;

EID: 31744438176     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-006-1543-7     Document Type: Review

References (96)

1. Achermann R, Ohlert SM, Bley CR, et al. Oxygenation of spontaneous canine tumors during fractionated radiation therapy. Strahlenther Onkol 2004;180:297-305.
2. Adam MF, Gabalski EC, Bloch DA, et al. Tissue oxygen distribution in head and neck cancer patients. Head Neck 1999;21:146-153.
3. Becker A, Hänsgen G, Bloching M, et al. Oxygenation of squamous cell carcinoma of the head and neck: comparison of primary tumors, neck node metastases, and normal tissue. Int J Radiat Oncol Biol Phys 1998;42:35-41.
4. Becker A, Stadler P, Hänsgen G, et al. Hemoglobin level influences the oxygenation status of squamous cell carcinoma of the head and neck (SCCHN) Int J Radiat Oncol Biol Phys 1998;42:Suppl 1:233.
5. Becker A, Stadler P, Lavey RS, et al. Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 2000;46:459-66.
6. Birgegard G, Aapro MS, Bokemeyer C, et al. Cancer-related anemia: pathogenesis, prevalence and treatment. Oncology 2005;68:3-11.
7. Brizel DM, Dodge RK, Clough RW, et al. Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. Radiother Oncol 1999;53:113-7.
8. Brizel DM, Scully SP, Harrelson JM, et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 1996;56:941-3.
9. Brizel DM, Sibley GS, Prosnitz LR, et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1997;38:285-9.
10. Caro JJ, Salas M, Ward A, et al. Anemia as an independent prognostic factor for survival in patients with cancer. A systemic quantitative review. Cancer 2001;91:2214-21.
11. Clarke H, Pallister CJ. The impact of anaemia on outcome in cancer. Clin Lab Haematol 2005;27:1-13.
12. 2 on tumour oxygenation in advanced head and neck tumours. Radiother Oncol 2003;66:71-4.
13. Coleman CN, Mitchell JB, Camphausen K. Tumor hypoxia: chicken, egg, or a piece of the farm? J Clin Oncol 2002;20:610-5.
14. Dietz A, Rudat V, Conradt C, et al. Prognostischer Stellenwert des Hämoglobinwertes vor primärer Radiochemotherapie von Kopf-Hals-Karzinomen. HNO 2000;48:655-64.
15. Dunst J. The use of epoietin alfa to increase and maintain hemoglobin levels during radiotherapy. Semin Oncol 2001;28:Suppl 8:42-8.
16. Dunst J. Management of anemia in patients undergoing curative radiotherapy. Erythropoietin, transfusions or better nothing? Strahlenther Onkol 2004;180:671-81.
17. Dunst J, Kuhnt T, Strauss HG, et al. Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis. Int J Radiat Oncol Biol Phys 2003;56:778-87.
18. Dunst J, Molls M. Relationship between anemia and hypoxia. In: Nowrousian MR, ed. Recombinant human erythropoietin (rhEPO) in clinical oncology. Wien-New York: Springer, 2002:117-25.
19. Evans SM, Koch CJ. Prognostic significance of tumor oxygenation in humans. Cancer Lett 2003;195:1-16.
20. Fyles AW, Milosevic M, Pintilie M, et al. Anemia, hypoxia and transfusion in patients with cervix cancer: a review. Radiother Oncol 2000;57:13-9.
21. Fyles AW, Milosevic M, Wong R, et al. Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol 1998;48:149-56.
22. Glaser C, Millesi W, Kornek GV, et al. Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys 2001;50:705-15.
23. Golab J, Olszewska D, Mróz P, et al. Erythropoietin restores the antitumor effectiveness of photodynamic therapy in mice with chemotherapy-induced anemia. Clin Cancer Res 2002;8:1265-70.
24. Grogan M, Thomas GM, Melamed I, et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 1999;86:1528-36.
25. Hänsgen G, Krause U, Becker A, et al. Tumor hypoxia, p53, and prognosis in cervical cancers. Int J Radiat Oncol Biol Phys 2001;50:865-72.
26. Harrison LB, Chadha M, Hill RJ, et al. Impact of tumor hypoxia and anemia on radiation therapy outcomes. Oncologist 2002;7:492-508.
27. Harrison LB, Shasha D, Homel P. Prevalence of anemia in cancer patients undergoing radiotherapy: prognostic significance and treatment. Oncology 2002;63:11-8.
28. Henke M, Sindlinger F, Ikenberg H, et al. Blood hemoglobin level and treatment outcome of early breast cancer. Strahlenther Onkol 2004;180:45-51.
29. Highley MS, de Bruin EA. Erythrocytes and the transport of drugs and endogenous compounds. Pharm Res 1996;13:186-95.
30. 2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 1993;26:45-50.
31. Höckel M, Schlenger K, Aral B, et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996;56:4509-15.
32. Höckel M, Schlenger K, Höckel S, et al. Tumor hypoxia in pelvic recurrences of cervical cancer. Int J Cancer 1998;79:365-9.
33. Höckel M, Vaupel P. Biological consequences of tumor hypoxia. Semin Oncol 2001;28:Suppl 8:36-41.
34. Höckel M, Vaupel P. Prognostic significance of tissue hypoxia in cervical cancer. CME J Gynecol Oncol 2001;6:216-25.
35. 2 availability during hemodilution. Adv Exp Med Biol 1984;180:281-91.
36. Kelleher DK, Matthiensen U, Thews O, et al. Tumor oxygenation in anemic rats: effects of erythropoietin treatment versus red blood cell transfusion. Acta Oncol 1995;34:379-84.
37. Kelleher DK, Matthiensen U, Thews O, et al. Blood flow, oxygenation, and bioenergetic status of tumors following erythropoietin treatment in normal and anemic rats. Cancer Res 1996;56:4728-34.
38. Kelleher DK, Thews O, Vaupel P. Can erythropoietin improve tumor oxygenation? Strahlenther Onkol 1998;174:Suppl IV:20-3.
39. Kelleher DK, Thews O, Vaupel P. Modulation of tumor oxygenation and radiosensitivity by erythropoietin. In: Vaupel P, Kelleher DK, eds. Tumor hypoxia. Pathophysiology, clinical significance and therapeutic perspectives. Stuttgart: Wissenschaftliche Verlagsgesellschaft, 1999:83-90.
40. 2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix. Radiother Oncol 1999;53:99-104.
41. Lally BE, Colasanto JM, Fischer JJ, et al. Is there an optimal hemoglobin level for patients with glioblastoma multiforme? Cancer J 2004;10:391-6.
42. Lavey RS. Clinical trial experience using erythropoietin during radiation therapy. Strahlenther Onkol 1998;174:24-30.
43. Lavey RS, McBride WH. Influence of hematocrit on tumor oxygenation and sensitivity to radiation. Eur J Cancer 1993;29A:Suppl 6:S216.
44. Littlewood TJ. The impact of hemoglobin levels on treatment outcomes in patients with cancer. Semin Oncol 2001;28:Suppl 8:49-53.
45. Ludwig H, van Belle S, Barrett-Lee P, et al. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer 2004;40:2293-306.
46. Lutterbach J, Guttenberger R. Anemia is associated with decreased local control of surgically treated squamous cell carcinomas of the glottic larynx. Int J Radiat Oncol Biol Phys 2000;48:1345-50.
47. Mayer R, Hamilton-Farrell MR, van der Kleij AJ, et al. Hyperbaric oxygen and radiotherapy. Strahlenther Onkol 2005;181:113-23.
48. Mertzlufft F. Normal values for hemoglobin concentration. In: Zander R, Mertzlufft F, eds. The oxygenation status of arterial blood. Basel-New York: Karger, 1991:162-6.
49. Milosevic M, Quirt I, Levin W, et al. Intratumoral sickling in a patient with cervix cancer and sickle trait: effect on blood flow and oxygenation. Gynecol Oncol 2001;83:428-31.
50. Molls M, Stadler P, Becker A, et al. Relevance of oxygen in radiation oncology. Mechanisms of action, correlation to low hemoglobin levels. Strahlenther Onkol 1998;174:Suppl IV:13-6.
51. Ning S, Hartley C, Molineux G, et al. Darbepoietin alfa potentiates the efficacy of radiation therapy in mice with corrected or uncorrected anemia. Cancer Res 2005;65:284-90.
52. Nordsmark M, Alsner J, Keller J, et al. Hypoxia in human sof tissue sarcomas: adverse impact on survival and no association with p53 mutations. Br J Cancer 2001;84:1070-5.
53. Nordsmark M, Bentzen SM, Rudat V, et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 2005;77:18-24.
54. Nordsmark M, Overgaard J. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiother Oncol 2000;57:39-43.
55. Nordsmark M, Overgaard J. Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer. Acta Oncol 2004;43:396-403.
56. Nordsmark M, Overgaard M, Overgaard J. Pretreatmentoxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 1996;41:31-9.
57. Nowrousian MR. Prevalence, pathophysiology, predictive factors, and prognostic significance of anemia in cancer chemotherapy. In: Nowrousian MR, ed. Recombinant human erythropoietin (rhEPO) in clinical oncology, 2nd edn. Wien-New York: Springer, 2002:63-100.
58. Okunieff P, Ding I, Vaupel P, et al. Evidence for and against hypoxia as the primary cause of tumor aggressiveness. Adv Exp Med Biol 2003;510:69-75.
59. Osterborg A. Anaemia in patients with cancer: association to prognosis and prediction of response to erythropoietic agents. In: Bokemeyer C, Ludwig H, eds. Anaemia in cancer, 2nd edn. Edinburgh-London-New York: Elsevier, 2005:75-89.
60. Pinel S, Barberi-Heyob M, Cohen-Jonathan E, et al. Erythropoietin-induced reduction of hypoxia before and during fractionated irradiation contributes to improvement of radioresponse in human glioma xenografts. Int J Radiat Oncol Biol Phys 2004;59:250-9.
61. Pitson G, Fyles A. Uterine cervix cancer. In: Gospodarowicz MK, Henson DE, Hutter RVP, et al., eds. Prognostic factors in cancer, 2nd edn. New York: Wiley-Liss, 2001:501-13.
62. Rudat V, Dietz A, Schramm O, et al. Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy. Radiother Oncol 1999;53:119-25.
63. 2 histography in patients with advanced head and neck cancer. Strahlenther Onkol 2001;177:462-8.
64. 2 histography in patients with advanced head and neck cancer. Radiother Oncol 2000;57:31-7.
65. Schrijvers D, Highley M, de Bruin E, et al. Role of red blood cells in pharmacokinetics of chemotherapeutic agents. Anticancer Drugs 1999;10:147-53.
66. Shannon AM, Bouchier-Hayes DJ, Condron CM, et al. Correction of anaemia through the use of darbepoetin alfa improves chemotherapeutic outcome in a murine model of Lewis lung carcinoma. Br J Cancer 2005;93:224-32.
67. Silver DF, Piver MS. Effects of recombinant human erythropoietin on the antitumor effect of cisplatin in SCID mice bearing human ovarian cancer: a possible oxygen effect. Gynecol Oncol 1999;73:280-4.
68. Spivak JL. The anaemia of cancer: death by a thousand cuts. Nat Rev Cancer 2005;5:543-55.
69. Stadler P, Becker A, Feldmann HJ, et al. Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. Int J Radiat Oncol Biol 1999;44:749-54.
70. Stone JE, Parker R, Gilks CB, et al. Intratumoral oxygenation of invasive squamous cell carcinoma of the vulva is not correlated with regional lymph node metastasis. Eur J Gynaecol Oncol 2005;26:31-5.
71. Stuben G, Pöttgen C, Knühmann K, et al. Erythropoietin restores the anemia-induced reduction in radiosensitivity of experimental human tumors in nude mice. Int J Radiat Oncol Biol Phys 2003;55:1358-62.
72. Stüben G, Thews O, Pöttgen C, et al. Recombinant human erythropoietin increases the radiosensitivity of xenografted human tumours in anaemic nude mice. J Cancer Res Clin Oncol 2001;127:346-50.
73. Stüben G, Thews O, Pöttgen C, et al. Impact of anemia prevention by recombinant human erythropoietin on the sensitivity of xenografted glioblastomas to fractionated irradiation. Strahlenther Onkol 2003;179:620-5.
74. 2 in cervix carcinoma. Gynecol Oncol 1997;64:230-6.
75. Sundfør K, Lyng H, Trope CG, et al. Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: relationships to pretreatment tumor oxygenation and vascularization. Radiother Oncol 2000;54:101-7.
76. Tarnawski R, Skladowski K, Maciejewski B. Prognostic value of hemoglobin concentration in radiotherapy for cancer of supraglottic larynx. Int J Radiat Oncol Biol Phys 1997;38:1007-11.
77. Terris DJ, Dunphy EP. Oxygen tension measurements of head and neck cancers. Arch Otolaryngol Head Neck Surg 1994;120:283-7.
78. 2 induced by erythropoietin. Adv Exp Med Biol 1994;361:613-8.
79. Thews O, Kelleher DK, Vaupel P. Erythropoietin restores the anemia-induced reduction in cyclophosphamide cytotoxicity in rat tumors. Cancer Res 2001;61:1358-61.
80. Thews O, Koenig R, Kelleher DK, et al. Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemia. Br J Cancer 1998;78:752-6.
81. Thomas G. The effect of hemoglobin level on radiotherapy outcomes: the Canadian experience. Semin Oncol 2001;28:Suppl 8:60-5.
82. Thomas L. Hämoglobine. In: Thomas L, Hrsg. Labor und Diagnose, 5. Aufl. Frankfurt: TH Books, 1998:487-91.
83. Tovari J, Gilly R, Raso E, et al. Recombinant human erythropoietin alpha targets intratumoral blood vessels, improving chemotherapy in human xenograft models. Cancer Res 2005;65:7186-93.
84. Van Belle SJ-P, Cocquyt V. Impact of haemoglobin levels on the outcome of cancers treated with chemotherapy. Crit Rev Oncol Hematol 2003;47:1-11.
85. Vaupel P. Blood flow, oxygenation, tissue pH distribution and bioenergetic status of tumors. Lecture 23. Berlin: Ernst Schering Research Foundation, 1994.
86. Vaupel P. Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol 2004;14:198-206.
87. Vaupel P, Briest S, Höckel M. Hypoxia in breast cancer: pathogenesis, characterization and biological/therapeutic implications. Wien Med Wochenschr 2002;152:334-42.
88. Vaupel P, Dunst J, Engert A, et al. Effects of recombinant human erythropoietin (rHuEPO) on tumor control in patients with cancer-induced anemia. Ontologie 2005;28:216-21.
89. Vaupel P, Mayer A. Erythropoietin to treat anaemia in patients with head and neck cancer. Lancet 2004;363:992.
90. Vaupel P, Mayer A. Effects of anaemia and hypoxia on tumour biology. In: Bokemeyer C, Ludwig H, eds. Anaemia in cancer, 2nd edn. Edinburgh-London-New York: Elsevier, 2005:47-66.
91. Vaupel P, Mayer A, Briest S, et al. Oxygenation gain factor: a novel parameter characterizing the association between hemoglobin level and the oxygenation status of breast cancers. Cancer Res 2003;63:7634-7.
92. Vaupel P, Thews O, Hoeckel M. Treatment resistance of solid tumors. Med Oncol 2001;18:243-59.
93. Vaupel P, Thews O, Mayer A, et al. Oxygenation status of gynecologic tumors: what is the optimal hemoglobin level? Strahlenther Onkol 2002;178:727-31.
94. Wagner W, Hermann R, Hartlapp J, et al. Prognostic value of hemoglobin concentrations in patients with advanced head and neck cancer treated with combined radio-chemotherapy and surgery. Strahlenther Onkol 2000;176:73-80.
95. -/- tumors is independent of tumor vessel density and correlates with melphalan erythrocyte transport. Int J Cancer 2002;99:514-9.
96. Zander R. Optimaler Hämatokrit 30%: Abschied von einer Illusion. Infusionsther Transfusionsmed 1999;26:186-90.